Veeda Clinical Research Pvt Ltd
We are one of the largest Independent CROs in India with a scientific edge, technical skills and better foresight for BA BE Studies & Clinical trials; with an objective of becoming a catalyst for enhanced drug developments to facilitate better patient treatments.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Havas Life London
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…
Advertising, Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs
Sciterion
Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…
Streaming Well
Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual stories and interactive experiences that connect with people.
Uniphar
Uniphar Group is a trusted global partner to pharmaceutical, medtech, and supply chain and retail companies, working to improve patient access to medicines around the world.
Company Details
Latest Content from PMHub
Behavioural Science in Healthcare
White Papers and Resources | December 4, 2019 | Page & Page Health
Personal health and wellbeing has never been more a part of the public conscious than it is now.
Why aren’t doctors using digital therapeutics?
White Papers and Resources | December 4, 2019 | Blue Latitude Health
The digital therapeutics market is set to reach almost $1 billion by 2026 as wearables and apps continue to play an important role in enhancing healthcare. However, adoption of these...
Four Health wins Judges Special Recognition Award PMEA 2019
Press Releases | November 29, 2019 | Four Agency Worldwide
We’re delighted to have won the Judge’s Special Recognition Award at the PMEA Awards 2019! Huge congratulations to the whole team for another amazing win for the GLAD I Took...
Lucid Group announces the appointment of a new Legal and Compliance manager
Press Releases | November 27, 2019 | Lucid Group Communications Limited
Lucid Group demonstrates continual investment in its infrastructure by appointing Sebastian Goodwin as its new Legal and Compliance manager.Sebastian studied politics and trained to be a lawyer before moving into...
Lucid Group Experience the Magic of Mindfulness, Meditation and Massage
Press Releases | November 27, 2019 | Lucid Group Communications Limited
This time of year can be busier than normal. Lucid Group understand the importance of taking some time out to relax and unwind. That's why yesterday, relaxation, meditation and mindfulness...
Are you using Patient-Reported Outcomes (PROs) in your oncology trials? If not, why not?
White Papers and Resources | November 27, 2019 | OPEN Health
A recent blog, published by Sarah Tressel Gary and Rinah Yamamoto called “Patient-Reported Outcome Data in Oncology Trials - Part 2: Clinical Benefit and Patient Preference”, has sparked our interest....
Bedrock’s on fire for Wellbeing Week
Press Releases | November 26, 2019 | Resonant Group
Bedrock creates a positive working environment to enable individuals and our business to thrive.
WHITE PAPER: Patient nonadherence – the $637bn paradox
White Papers and Resources | November 25, 2019 | IGNIFI
What’s not changed for 50 years, kills 200,000 Europeans annually, costs pharma $637 billion and the NHS over £500 million a year? We’ll tell you.
Spotlight interview: 15 minutes on insights and market research in pharma
White Papers and Resources | November 21, 2019 | OPEN Health
Neil Rees, Head of Research, OPEN Health Patient & Brand Communication takes 15 minutes to answer some key questions on insights and market research in pharma
Early diagnosis underpins NHS cancer strategy
White Papers and Resources | November 20, 2019 | Wilmington Healthcare
Paul Midgley, Oli Hudson and Sarah Shield, of Wilmington Healthcare, explore how the NHS is tackling cancer in line with the Long-term Plan